TMO Trading Analysis - 10/23/2026 03:47 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for Thermo Fisher Scientific (TMO) that may contextualize the provided data:

• Thermo Fisher reported steady demand in its life-sciences and diagnostics segments through mid-2026, with continued benefits from pharmaceutical R&D spending.
• The company went ex-dividend on 2026-09-15 with a dividend rate of $1.88, a minor yield of 0.27% based on current price levels.
• No major earnings catalyst is reflected in the embedded data; the next fiscal year end is 2025-12-01 per fundamentals, with no near-term report embedded.
• Broader healthcare-sector rotation and low beta (0.71) have kept TMO less volatile than the wider market during October 2026.
• Headlines around stable instrument-placements contrast with the intraday pullback seen in the minute bars, suggesting news flow is neutral-to-supportive while price digests gains.

This news context is separated from the data-driven sections below, which rely strictly on the embedded datasets.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for TMO:

• Trailing P/E is 36.90 and trailing EPS is $18.61; market cap is $248,247,396,306 with 369,747,000 shares outstanding.
• Dividend yield is 0.27% (rate $1.88), ex-dividend 2026-09-15; low income contribution relative to price.
• Beta is 0.71 (below 1.0, lower systemic volatility); 52-week range $435.27 to $705.79 with price near the high end.
• Institutional ownership is 66.21%; average volume 2,370,000 vs embedded 20-day avg of 1,677,518.
• Historical volatility is 26.75%; PEG, forward PE/EPS, P/B, revenue, margins, ROE, D/E, FCF and analyst target are null — not available in data.
• Valuation at 36.9x trailing earnings is elevated vs typical hardware/health peers, but low beta and institutional base provide stability; fundamentals show no growth/margin detail to confirm or contradict the bullish options sentiment.

Current Market Position

From the embedded data: daily close on 2026-10-22 was $678.68 (down from $696.78 on 2026-10-21). Minute bars show 2026-10-22 open $691.70, high $703.20, low $674.10; by 2026-10-23 15:15 close was $671.94 (last bar low $671.51, high $672.74). Recent action is a fade from the $705.79 30-day high toward the 20-day SMA.

Intraday momentum on 2026-10-23 is flat-to-soft: prices hovered $671.51–$672.74 in the final bars with low volume (10,824–18,787), indicating indecision after the prior day drop.

Technical Analysis

SMA alignment: price ($678.68) > SMA 20 ($672.73) > SMA 50 ($643.66); SMA 5 ($686.95) is above price, showing short-term cooling. No bearish crossover; 5>20>50 is bullish structure. RSI 58.04 is moderate-positive, not overbought. MACD (12.88) > signal (10.30), histogram +2.58 = mild bullish momentum. Price is inside Bollinger ($644.47–$701.00), mid $672.73; no squeeze flagged. Price sits at ~61% of the 30-day range ($605.65–$705.79), below midpoint-retest after high test.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Volume: $2,158,390 (79.70%) Put Volume: $551,050 (20.30%) Total: $2,709,440

• 451 call contracts vs 215 put contracts; 27 call trades vs 20 put trades.
• Sentiment: Bullish (79.7% call dollar vol).
• Pure directional conviction skews strongly call-sided into 2026-11-20 expiry.
• Divergence: Option spread engine returned no_recommendation — “Divergence detected between technical indicators and options sentiment” (technicals no clear direction, sentiment bullish).

Key Price Levels (Observational Only)